{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T01:35:43Z","timestamp":1780364143764,"version":"3.54.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T00:00:00Z","timestamp":1524787200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12883-018-1061-0","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T01:12:34Z","timestamp":1524791554000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Case series of Creutzfeldt-Jakob disease in a third-level hospital in Quito"],"prefix":"10.1186","volume":"18","author":[{"given":"Germaine Eleanor","family":"Torres Herr\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s Dami\u00e1n","family":"Ortega Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Braulio Martinez","family":"Burbano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Serrano-Due\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Ang\u00e9lica","family":"Ortiz Yepez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal Alberto","family":"Barrera Madera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Alfredo","family":"Masabanda Campa\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo David","family":"Ba\u00f1o Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denny Maritza","family":"Santos Saltos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar Patricio","family":"Correa D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,27]]},"reference":[{"key":"1061_CR1","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1750-3639.1996.tb00869.x","volume":"6","author":"JW Ironside","year":"1996","unstructured":"Ironside JW. Creutzfeldt-Jakob disease. Brain Pathol. 1996;6:379\u201388.","journal-title":"Brain Pathol"},{"key":"1061_CR2","doi-asserted-by":"publisher","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","volume":"95","author":"SB Prusiner","year":"1998","unstructured":"Prusiner SB. Prions. Proc Natl Acad Sci U S A. 1998;95:13363\u201383.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1061_CR3","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1056\/NEJM200105173442006","volume":"344","author":"SB Prusiner","year":"2001","unstructured":"Prusiner SB. Neurodegenerative diseases and prions. N Engl J Med. 2001;344:1516\u201326.","journal-title":"N Engl J Med"},{"key":"1061_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1651-2227.1999.tb14400.x","volume":"88","author":"RG Will","year":"1999","unstructured":"Will RG. The transmission of prions to humans. Acta Paediatr Suppl. 1999;88:28\u201332.","journal-title":"Acta Paediatr Suppl"},{"key":"1061_CR5","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1073\/pnas.0305777101","volume":"101","author":"C Casalone","year":"2004","unstructured":"Casalone C, Zanusso G, Acutis P, Ferrari S, Capucci L, Tagliavini F, et al. Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease. Proc Natl Acad Sci U S A. 2004;101:3065\u201370.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1061_CR6","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1093\/hmg\/6.10.1699","volume":"6","author":"J Collinge","year":"1997","unstructured":"Collinge J. Human prion diseases and bovine spongiform encephalopathy (BSE). Hum Mol Genet. 1997;6:1699\u2013705.","journal-title":"Hum Mol Genet"},{"key":"1061_CR7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.cll.2009.11.002","volume":"30","author":"S Venneti","year":"2010","unstructured":"Venneti S. Prion diseases. Clin Lab Med. 2010;30:293\u2013309.","journal-title":"Clin Lab Med"},{"key":"1061_CR8","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.ncl.2007.03.006","volume":"25","author":"E Eggenberger","year":"2007","unstructured":"Eggenberger E. Prion disease. Neurol Clin. 2007;25:833\u201342.","journal-title":"Neurol Clin"},{"key":"1061_CR9","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S1474-4422(05)70192-7","volume":"4","author":"RT Johnson","year":"2005","unstructured":"Johnson RT. Prion diseases. Lancet Neurol. 2005;4:635\u201342.","journal-title":"Lancet Neurol"},{"key":"1061_CR10","first-page":"548","volume":"47","author":"A Panagariya","year":"1999","unstructured":"Panagariya A, Jain RS, Sharma AK. Stroke like presentation of Creutzfeldt-Jakob disease: an unusual variant. J Assoc Physicians India. 1999;47:548\u201350.","journal-title":"J Assoc Physicians India"},{"key":"1061_CR11","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S1474-4422(12)70063-7","volume":"11","author":"G Puoti","year":"2012","unstructured":"Puoti G, Bizzi A, Forloni G, Safar JG, Tagliavini F, Gambetti P. Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol. 2012;11:618\u201328.","journal-title":"Lancet Neurol"},{"key":"1061_CR12","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1177\/0891988710383576","volume":"23","author":"K Brown","year":"2010","unstructured":"Brown K, Mastrianni JA. The prion diseases. J Geriatr Psychiatry Neurol. 2010;23:277\u201398.","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"1061_CR13","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1055\/s-0033-1359314","volume":"33","author":"L Takada","year":"2013","unstructured":"Takada L, Geschwind MD. Prion diseases. Semin Neurol. 2013;33:348\u201356.","journal-title":"Semin Neurol"},{"key":"1061_CR14","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/WCO.0000000000000197","volume":"28","author":"MO Kim","year":"2015","unstructured":"Kim MO, Geschwind MD. Clinical update of Creutzfeldt-Jakob disease. Curr Opin Neurol. 2015;28:302\u201310.","journal-title":"Curr Opin Neurol"},{"key":"1061_CR15","doi-asserted-by":"publisher","first-page":"E2","DOI":"10.3171\/2015.8.FOCUS15328","volume":"39","author":"M Manix","year":"2015","unstructured":"Manix M, Kalakoti P, Henry M, Thakur J, Menger R, Guthikonda B, et al. Creutzfeldt-Jakob disease: updated diagnostic criteria, treatment algorithm, and the utility of brain biopsy. Neurosurg Focus. 2015;39:E2.","journal-title":"Neurosurg Focus"},{"key":"1061_CR16","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1093\/brain\/awh575","volume":"128","author":"HJ Tschampa","year":"2005","unstructured":"Tschampa HJ, Kallenberg K, Urbach H, Meissner B, Nicolay C, Kretzschmar HA, et al. MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease: a study on inter-observer agreement. Brain. 2005;128:2026\u201333.","journal-title":"Brain"},{"key":"1061_CR17","volume-title":"Proyecciones poblacionales","author":"Instituto Nacional de Estad\u00edsticas (INEC)","year":"2016","unstructured":"Instituto Nacional de Estad\u00edsticas (INEC). Proyecciones poblacionales 2016. Available in: \n                    www.ecuadorencifras.gob.ec\n                    \n                  ."},{"key":"1061_CR18","unstructured":"Instituto Ecuatoriano de Seguridad Social (IESS). Rendici\u00f3n de cuentas 2016. Available in: \n                    www.iess.gob.ec\/es\/web\/guest\/rendicion-de-cuentas-2016\n                    \n                  ."},{"key":"1061_CR19","first-page":"71","volume":"18","author":"F Alarc\u00f3n","year":"2009","unstructured":"Alarc\u00f3n F, Salinas R, R\u00e1bano A. Enfermedad de Creutzfeldt Jakob Espor\u00e1dico: Presentaci\u00f3n del Primer Caso Cl\u00ednico \u2013 Patol\u00f3gico en Ecuador. Rev Ecuat Neurol. 2009;18:71\u20135.","journal-title":"Rev Ecuat Neurol"},{"key":"1061_CR20","first-page":"364","volume":"31","author":"L Torres","year":"2014","unstructured":"Torres L, Ram\u00edrez J, Cosentino C, V\u00e9lez M, Flores M, Rivas D, et al. Creutzfeldt-Jakob disease in Peru: report of eleven cases. Rev Peru Med Exp Salud P\u00fablica. 2014;31:364\u20139.","journal-title":"Rev Peru Med Exp Salud P\u00fablica"},{"key":"1061_CR21","doi-asserted-by":"publisher","first-page":"136","DOI":"10.14802\/jmd.15014","volume":"8","author":"P Lolekha","year":"2015","unstructured":"Lolekha P, Rasheed A, Yotsarawat C. Creutzfeldt-Jakob disease in a tertiary Care Hospital in Thailand: a case series and review of the literature. J Mov Disord. 2015;8:136\u201340.","journal-title":"J Mov Disord"},{"key":"1061_CR22","doi-asserted-by":"publisher","first-page":"e24231","DOI":"10.1371\/journal.pone.0024231","volume":"6","author":"C Gao","year":"2011","unstructured":"Gao C, Shi Q, Tian C, Chen C, Han J, Zhou W, et al. The epidemiological, clinical, and laboratory features of sporadic Creutzfeldt-Jakob disease patients in China: surveillance data from 2006 to 2010. PLoS One. 2011;6:e24231.","journal-title":"PLoS One"},{"key":"1061_CR23","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1093\/brain\/awp191","volume":"132","author":"I Zerr","year":"2009","unstructured":"Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain. 2009;132:2659\u201368.","journal-title":"Brain"},{"key":"1061_CR24","unstructured":"Criteria for diagnosis of sCJD [The University of Edinburgh web site]. 2017. Available at: \n                    http:\/\/www.cjd.ed.ac.uk\/sites\/default\/files\/diagnostic%20criteria.pdf\n                    \n                  . Accessed 9 Mar 2017."},{"key":"1061_CR25","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.clinph.2005.12.007","volume":"117","author":"HG Wieser","year":"2006","unstructured":"Wieser HG, Schindler K, Zumsteg D. EEG in Creutzfeldt-Jakob disease. Clin Neurophysiol. 2006;117:935\u201351.","journal-title":"Clin Neurophysiol"},{"key":"1061_CR26","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1212\/WNL.55.6.811","volume":"55","author":"I Zerr","year":"2000","unstructured":"Zerr I, Pocchiari M, Collins S, Brandel JP, de Pedro CJ, Knight RS, et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology. 2000;55:811\u20135.","journal-title":"Neurology"},{"key":"1061_CR27","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1212\/WNL.0b013e31826d5fc3","volume":"79","author":"T Muayqil","year":"2012","unstructured":"Muayqil T, Gronseth G, Camicioli R. Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease report of the guideline development subcommittee of the American academy of neurology. Neurology. 2012;79:1499\u2013506.","journal-title":"Neurology"},{"key":"1061_CR28","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1093\/brain\/aws238","volume":"135","author":"K Stoeck","year":"2012","unstructured":"Stoeck K, Sanchez-Juan P, Gawinecka J, Green A, Ladogana A, Pocchiari M, et al. Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt\u2013Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years. Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years. Brain. 2012;135:3051\u201361.","journal-title":"Brain"},{"key":"1061_CR29","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1212\/01.WNL.0000135153.96325.3B","volume":"63","author":"RJ Castellani","year":"2004","unstructured":"Castellani RJ, Colucci M, Xie Z, Zou W, Li C, Parchi P, et al. Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease. Neurology. 2004;63:436\u201342.","journal-title":"Neurology"},{"key":"1061_CR30","doi-asserted-by":"publisher","first-page":"15283","DOI":"10.1038\/srep15283","volume":"5","author":"JW Hyeon","year":"2015","unstructured":"Hyeon JW, Kim SY, Lee J, Park JS, Hwang KJ, Lee SM, et al. Alternative application of tau protein in Creutzfeldt-Jakob disease diagnosis: improvement for weakly positive 14-3-3 protein in the laboratory. Sci Rep. 2015;5:15283.","journal-title":"Sci Rep"},{"key":"1061_CR31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/1471-2377-11-133","volume":"11","author":"M Coulthart","year":"2011","unstructured":"Coulthart M, Jansen G, Olsen E, Godal D, Connolly T, Choi B, et al. Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study. BMC Neurol. 2011;11:133.","journal-title":"BMC Neurol"},{"key":"1061_CR32","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1212\/WNL.0b013e318263565f","volume":"79","author":"C Hamlin","year":"2012","unstructured":"Hamlin C, Puoti G, Berri S, Sting E, Harris C, Cohen M, et al. A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease. Neurology. 2012;79:547\u201352.","journal-title":"Neurology"},{"key":"1061_CR33","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1212\/01.WNL.0000134555.59460.5D","volume":"63","author":"Y Shiga","year":"2004","unstructured":"Shiga Y, Miyazawa K, Sato S, Fukushima R, Shibuya S, Sato Y, et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology. 2004;63:443\u20139.","journal-title":"Neurology"},{"key":"1061_CR34","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1212\/WNL.0b013e31821a4439","volume":"76","author":"P Vitali","year":"2011","unstructured":"Vitali P, Maccagnano E, Caverzasi E, Henry RG, Haman A, Torres-Chae C, et al. Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology. 2011;76:1711\u20139.","journal-title":"Neurology"},{"key":"1061_CR35","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1136\/jnnp.2006.094821","volume":"78","author":"RG Macfarlane","year":"2007","unstructured":"Macfarlane RG, Wroe SJ, Collinge J, Yousry TA, J\u00e4ger HR. Neuroimaging findings in human prion disease. J Neurol Neurosurg Psychiatry. 2007;78:664\u201370.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1061_CR36","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1148\/rg.26si065503","volume":"26","author":"R Ukisu","year":"2006","unstructured":"Ukisu R, Kushihashi T, Tanaka E, Baba M, Usui N, Fujisawa H, et al. Diffusion-weighted MR imaging of early-stage Creutzfeldt-Jakob disease: typical and atypical manifestations. Radiographics. 2006;26:191\u2013204.","journal-title":"Radiographics"},{"key":"1061_CR37","first-page":"1551","volume":"26","author":"GS Young","year":"2005","unstructured":"Young GS, Geschwind MD, Fischbein NJ, Martindale JL, Henry RG, Liu S, et al. Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol. 2005;26:1551\u201362.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1061_CR38","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1073\/pnas.0409651102","volume":"102","author":"JG Safar","year":"2005","unstructured":"Safar JG, Geschwind MD, Deering C, Didorenko S, Sattavat M, Sanchez H, et al. Diagnosis of human prion disease. Proc Natl Acad Sci U S A. 2005;102:3501\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1061_CR39","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1056\/NEJMoa1315200","volume":"371","author":"CD Orr\u00fa","year":"2014","unstructured":"Orr\u00fa CD, Bongianni M, Tonoli G, Ferrari S, Hughson AG, Groveman BR, et al. A test for Creutzfeldt\u2013Jakob disease using nasal brushings. N Engl J Med. 2014;371:519\u201329.","journal-title":"N Engl J Med"},{"key":"1061_CR40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1574-695X.1998.tb01153.x","volume":"21","author":"JW Ironside","year":"1998","unstructured":"Ironside JW. Neuropathological findings in new variant CJD and experimental transmission of BSE. FEMS Immunol Med Microbiol. 1998;21:91\u20135.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"1061_CR41","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/j.1750-3639.1995.tb00625.x","volume":"5","author":"H Budka","year":"1995","unstructured":"Budka H, Aguzzi A, Brown P, Brucher JM, Bugiani O, Gullotta F, et al. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol. 1995;5:459\u201366.","journal-title":"Brain Pathol"},{"key":"1061_CR42","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1212\/01.WNL.0000113764.35026.EF","volume":"62","author":"M Otto","year":"2004","unstructured":"Otto M, Cepek L, Ratzka P, Doehlinger S, Boekhoff I, Wiltfang J, et al. Efficacy of flupirtine on cognitive function in patients with CJD: a double-blind study. Neurology. 2004;62:714\u20138.","journal-title":"Neurology"}],"updated-by":[{"DOI":"10.1186\/s12883-018-1088-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T00:00:00Z","timestamp":1528761600000}}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-018-1061-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-018-1061-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-018-1061-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T19:15:04Z","timestamp":1556306104000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-018-1061-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,27]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1061"],"URL":"https:\/\/doi.org\/10.1186\/s12883-018-1061-0","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12883-018-1088-2","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,27]]},"assertion":[{"value":"24 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2018","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Following publication of the original article [1], Andr\u00e9s Dami\u00e1n Ortega Heredia requested that his name be corrected from","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Carlos Andrade Mar\u00edn Hospital ethics committee. Written informed consent of participation was obtained from the legal guardians. A copy of the written consent is available for review by the Editor of this journal.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent to publish this case reports was given by the legal guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"55"}}